Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04143698 · ClinicalTrials.gov registry record · NA
Reusable Versus Disposable Duodenoscopes for ERCP
A NA study of Endoscopic Retrograde Cholangiopancreatography, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT04143698: Completed NA study of Endoscopic Retrograde Cholangiopancreatography, sponsored by AdventHealth.
NCT04143698 is a NA study of Endoscopic Retrograde Cholangiopancreatography that has completed, run by AdventHealth. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04143698, a NA study of Endoscopic Retrograde Cholangiopancreatography, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this randomized trial is to evaluate the technical aspects of disposable duodenoscopes and to compare the technical outcomes between the disposable (single-use) and reusable duodenoscopes.
Primary Outcome
The ease of cannulation of the desired duct (biliary or pancreatic), as measured by the total number of cannulation attempts to achieve successful cannulation of the desired duct.
Conditions Studied
Interventions
- DEVICE endoscopic retrograde cholangiopancreatography
Study Locations (1)
Florida
- AdventHealth Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2020-01-24 |
| Est. Completion | 2020-05-06 |
| Phase | NA |
What the finished NCT04143698 record still lists
NCT04143698 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Endoscopic Retrograde Cholangiopancreatography appearing as the primary indexed condition, and to 1 intervention - of which endoscopic retrograde cholangiopancreatography is the first listed.
NCT04143698 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04143698 about?
NCT04143698 is a clinical study titled "Reusable Versus Disposable Duodenoscopes for ERCP". The aim of this randomized trial is to evaluate the technical aspects of disposable duodenoscopes and to compare the technical outcomes between the disposable (single-use) and reusable duodenoscopes.
What is the current status of trial NCT04143698?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2020-01-24. Estimated completion is 2020-05-06.
What conditions does trial NCT04143698 study?
This clinical trial studies the following conditions: Endoscopic Retrograde Cholangiopancreatography.
What interventions are being tested in trial NCT04143698?
The interventions under investigation include: endoscopic retrograde cholangiopancreatography (DEVICE).
Who is sponsoring clinical trial NCT04143698?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04143698 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endoscopic Retrograde Cholangiopancreatography
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04143698's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI